Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis

BACKGROUND: In this pooled, post hoc analysis of a phase 2 trial and the phase 3 TEMSO, TOWER, and TENERE clinical trials, long-term efficacy and safety of teriflunomide were assessed in subgroups of patients with relapsing multiple sclerosis (MS) defined by prior treatment status. METHODS: Patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Comi, Giancarlo, Freedman, Mark S., Meca-Lallana, José E., Vermersch, Patrick, Kim, Byoung Joon, Parajeles, Alexander, Edwards, Keith R., Gold, Ralf, Korideck, Houari, Chavin, Jeffrey, Poole, Elizabeth M., Coyle, Patricia K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539502/
https://www.ncbi.nlm.nih.gov/pubmed/33023488
http://dx.doi.org/10.1186/s12883-020-01937-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539502/
https://www.ncbi.nlm.nih.gov/pubmed/33023488
http://dx.doi.org/10.1186/s12883-020-01937-4

Ejemplares similares